- Potential benefitMay reduce plan proliferation and simplify choices for beneficiaries by shrinking the number of nearly identical or mar…
- Potential benefitCould lower administrative, marketing, and plan‑management costs for CMS and insurers over time by reducing the total n…
- Potential benefitMay reduce opportunities for insurers to create narrowly segmented or targeted plan variants that could be used to stee…
To amend title XVIII of the Social Security Act to impose limitations on contracts with Medicare Advantage organizations offering multiple Medicare Advantage plans under the Medicare program.
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for c…
The bill amends Section 1857 of the Social Security Act to limit the number and similarity of Medicare Advantage (MA) plans an MA organization may have under contract with the Medicare program. For contracts entered into or renewed one year after enactment, the Secretary may not contract with an MA organization for more than three MA plans for a plan year.
Whether the rule is a needed check on MA proliferation and beneficiary protection (liberal) versus an undue restriction on private competition and consumer choice (conservative).
Relative to its intended legislative type, this bill is a focused substantive amendment to the Social Security Act that establishes a straightforward prohibition and a conditional limitation on Medicare Advantage contracting.
The bill amends Section 1857 of the Social Security Act to limit the number and similarity of Medicare Advantage (MA) plans an MA organization may have under contract with the Medicare program.
For contracts entered into or renewed one year after enactment, the Secretary may not contract with an MA organization for more than three MA plans for a plan year.
In addition, the Secretary may not contract with an MA organization for more than one MA plan for a plan year unless each plan is "significantly different" from the others with respect to premiums, benefits, or cost-sharing, as determined by the Secretary.
On content alone this is a targeted regulatory restriction within Medicare that is implementable in statutory text, but it affects a powerful stakeholder sector (private insurers) and a politically sensitive program (Medicare). The absence of phased implementation, detailed cost analysis, or carve‑outs reduces prospects for broad consensus. Unless paired with negotiated compromises or offsetting concessions, the bill as written faces a low-to-moderate likelihood of enactment.
Relative to its intended legislative type, this bill is a focused substantive amendment to the Social Security Act that establishes a straightforward prohibition and a conditional limitation on Medicare Advantage contracting. It is clear about the main legal rule, where the amendment belongs in statute, the implementing authority, and the effective date.
Whether the rule is a needed check on MA proliferation and beneficiary protection (liberal) versus an undue restriction on private competition and consumer choice (conservative).
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- ConsumersLikely reduces consumer choice and the availability of narrowly tailored plan options (including specialized benefit st…
- Local governmentsCould prompt insurers to exit certain markets, discontinue specialized plans (including some special‑needs plans or reg…
- Potential burdenMay increase legal and administrative disputes over the undefined standard of what is ‘‘significantly different’’ (givi…
Why the argument around this bill splits.
Whether the rule is a needed check on MA proliferation and beneficiary protection (liberal) versus an undue restriction on private competition and consumer choice (conservative).
A mainstream liberal would generally view this bill as a curbing of Medicare Advantage plan proliferation that could reduce beneficiary confusion, aggressive marketing, and potential plan gaming of the Medicare payment system.
They would likely see it as a measure to simplify choices for beneficiaries and to limit practices that can erode traditional Medicare or steer beneficiaries into plans that are not in their best interest.
At the same time they may want safeguards so that reduced plan variety does not unintentionally reduce access or choice in certain local markets (especially rural areas).
A centrist/moderate would see both potential upsides (simpler choices for beneficiaries, easier oversight) and potential downsides (reduced competition, unintended market effects).
They would want evidence that caps on plans will not raise premiums, reduce innovation, or restrict access locally before endorsing the measure.
They would emphasize careful rule-writing, a limited and reversible pilot or phased approach, and coordination with state regulators and CMS data collection.
A mainstream conservative would likely view the bill as federal overreach into private insurance markets and an unnecessary restriction on consumer choice and market competition.
They would be wary that limiting the number of plans per organization interferes with insurers' ability to innovate and tailor products to different beneficiary needs.
They would also be concerned about increased regulatory burden, potential higher costs, and reduced private-sector participation in Medicare Advantage.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
On content alone this is a targeted regulatory restriction within Medicare that is implementable in statutory text, but it affects a powerful stakeholder sector (private insurers) and a politically sensitive program (Medicare). The absence of phased implementation, detailed cost analysis, or carve‑outs reduces prospects for broad consensus. Unless paired with negotiated compromises or offsetting concessions, the bill as written faces a low-to-moderate likelihood of enactment.
- No Congressional Budget Office or cost estimate is included in the text; the direction and magnitude of programmatic and federal spending effects are therefore uncertain.
- How the Secretary would interpret and apply the undefined standard ‘‘significantly different’’ (premiums, benefits, cost‑sharing) is left open and could materially affect impact and legal vulnerability.
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Whether the rule is a needed check on MA proliferation and beneficiary protection (liberal) versus an undue restriction on private competit…
On content alone this is a targeted regulatory restriction within Medicare that is implementable in statutory text, but it affects a powerf…
Relative to its intended legislative type, this bill is a focused substantive amendment to the Social Security Act that establishes a straightforward prohibition and a conditional limitation on Medicare Advantage contra…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.